KOBV Portal

Please enable Javascript in your browser preferences in order to use all features of KOBV Portal.

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Hits per page

hit 1 - 1 | 1 hit

Select All Export

1

Online Resource

Online Resource

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

Despierre, Evelyn ; on behalf of the European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG), Groupe d’Investigateurs Nationaux pour les Etudes des Cancers de l’Ovaire (GINECO), Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (A-AGO), National Cancer Research Institute (NCRI), Australia New Zealand Gynaecological Oncology Group (ANZGOG), and the Mario Negri Gynecologic Oncology group (MaNGO) ; Vergote, Ignace ; [et al.]

Springer Science and Business Media LLC ; 2015

In: Targeted Oncology Vol. 10, No. 4 ( 2015-12), p. 583-596

add to watchlist on the watchlist

Details

In: Targeted Oncology, Springer Science and Business Media LLC, Vol. 10, No. 4 ( 2015-12), p. 583-596

Type of Medium: Online Resource

ISSN: 1776-2596 , 1776-260X

URL: Article

DOI: 10.1007/s11523-015-0369-6

Language: English

Publisher: Springer Science and Business Media LLC

Publication Date: 2015

detail.hit.zdb_id: 2222136-0

Library	Location	Call Number	Volume/Issue/Year	Availability

BibTip

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

Link to publisher

hit 1 - 1 | 1 hit

This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages